에이사이클로비르

에이사이클로비르
에이사이클로비르 구조식 이미지
카스 번호:
59277-89-3
한글명:
에이사이클로비르
동의어(한글):
에이사이클로비르;에이사이클로비르(ACYCLOVIR)
상품명:
Acyclovir
동의어(영문):
ACICLOVIR;ACV;Acyclovir USP;ACETYLTHIAZOLE;ACYCLOGUANOSINE;ovir;AcycL;Zoviax;Zyclir;Vimrax
CBNumber:
CB7126677
분자식:
C8H11N5O3
포뮬러 무게:
225.2
MOL 파일:
59277-89-3.mol
MSDS 파일:
SDS

에이사이클로비르 속성

녹는점
256-257°C
끓는 점
366.71°C (rough estimate)
밀도
1.3654 (rough estimate)
굴절률
1.8000 (estimate)
저장 조건
2-8°C
용해도
H2O: 0.7 mg/mL
물리적 상태
가루
산도 계수 (pKa)
pKa 2.27 (Uncertain);9.25 (Uncertain)
색상
하얀색
수용성
50mg/ml의 1M HCl에 용해됩니다. 0.7mg/ml로 물에 용해됩니다. DMSO에도 용해됨
Merck
14,146
BCS Class
4,3
안정성
안정적인. 강한 산화제와 호환되지 않습니다.
InChIKey
MKUXAQIIEYXACX-UHFFFAOYSA-N
LogP
-0.617 (est)
CAS 데이터베이스
59277-89-3(CAS DataBase Reference)
IARC
3 (Vol. 76) 2000
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 Xi,Xn
위험 카페고리 넘버 36/37/38-40-20/21/22
안전지침서 22-24/25-36-26-23
WGK 독일 2
RTECS 번호 UP0791400
위험 등급 IRRITANT
HS 번호 29335990
유해 물질 데이터 59277-89-3(Hazardous Substances Data)
독성 LD50 in mice (mg/kg): >10,000 orally; 1000 i.p. (Schaeffer)
기존화학 물질 KE-01300
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H320 눈에 자극을 일으킴 심한 눈 손상 또는 자극성 물질 구분 2B 경고 P264, P305+P351+P338,P337+P313
예방조치문구:
P264 취급 후에는 손을 철저히 씻으시오.
P264 취급 후에는 손을 철저히 씻으시오.
NFPA 704
0
3 0

에이사이클로비르 MSDS


2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one

에이사이클로비르 C화학적 특성, 용도, 생산

용도

1. 대상포진
2. 초발 및 재발성 성기포진 감염증
3. 성기포진 감염증의 재발 억제
4. 안전한 성생활을 병행하는 경우 억제요법으로서 성기포진의 전염 감소
5. 신장이식 후 거대세포바이러스 감염 예방
6. 구순포진
7. 면역기능이 정상인 2세 이상 18세미만 소아의 수두

부작용

건조하고, 금이 가거나 입술이 벗겨진다.
치료 된 피부의 건조 또는 박편 화;
약을 바르면 화상, 가려움증 또는 가려움증.

개요

As it is evident from the chemical structure, acyclovir looks like a nucleoside analog of guanosine in side chain of which, instead of the traditional cyclic sugar residue a 2-hydroxyethoxymethyl acyclic side chain is present. Acyclovir possesses antiviral activity with respect to types 1 and 2 of herpes simplex, shingles virus, Epstein–Barr virus, and cytomegalovirus.

화학적 성질

white to light yellow crystal powder

용도

Acyclovir (Zovirax) is a synthetic purine analog derived from guanine. It exerts its effects on the herpes simplex virus (HSV) and varicella-zoster virus by interfering with DNA synthesis through phosphorylation by viral thymidine kinase and subsequent inhibition of viral DNA polymerase, thereby inhibiting viral replication. It is effective against HSV-1 and 2, varicella-zoster virus, Epstein-Barr virus, herpesvirus simiae, and cytomegalovirus. Acyclovir may be administered intravenously, orally, or topically.
Acyclovir Ointment

정의

ChEBI: An oxopurine that is guanine substituted by a (2-hydroxyethoxy)methyl substituent at position 9.

Indications

Acyclovir (Zovirax) is a synthetic purine analog derived from guanine. It exerts its effects on the herpes simplex virus (HSV) and varicella-zoster virus by interfering with DNA synthesis through phosphorylation by viral thymidine kinase and subsequent inhibition of viral DNA polymerase, thereby inhibiting viral replication. It is effective against HSV-1 and 2, varicella-zoster virus, Epstein-Barr virus, herpesvirus simiae, and cytomegalovirus. Acyclovir may be administered intravenously, orally, or topically.
Acyclovir (400 mg PO b.i.d. or 200 mg PO five times a day) or other antiviral antibiotics can suppress herpes-associated EM. It is of no value once the EM has started. Not all episodes of a herpes simplex recurrence are associated with EM, but in recurrent cases, a 6-month trial of suppressive therapy can be helpful.

Antimicrobial activity

Activity is restricted to viruses of the herpes group. Herpes simplex virus (HSV) types 1 and 2, simian herpes virus B and varicella zoster viruses (VZV) are susceptible to concentrations readily attainable in human plasma. The 50% inhibitory concentration (ID50) is 0.1 μmol for HSV-1 and HSV-2 and 3 μmol for VZV, concentrations much below those toxic to cells. Valaciclovir is metabolized to aciclovir, and has the same antiviral profile. Thymidine-kinase-negative HSV mutants and cytomegalovirus (CMV) do not code for thymidine kinase and are generally resistant. Although Epstein–Barr virus (EBV) may have reduced thymidine kinase activity, its DNA polymerase is susceptible to aciclovir triphosphate and shows intermediate susceptibility. Human herpes viruses 6 and 7 are less susceptible than EBV.

원료

Mutations in HSV that involve deficient thymidine kinase or an altered substrate are most common; alterations in the DNA polymerase gene also result in resistance. Resistant mutants may be found in wild virus populations; mutants lacking thymidine kinase activity may be readily induced by passage of HSV in the presence of the drug. Resistant strains have mostly been reported in immunocompromised patients, are generally thymidine-kinase negative, and have decreased virulence. Resistant mutants that retain thymidine kinase activity appear to retain virulence. Emergence of resistant HSV strains is less frequent in immunocompetent patients, occurring in about 2% of those receiving prolonged treatment.

일반 설명

Acyclovir, 9-[2-(hydroxyethoxy)methyl]-9H-guanine (Zovirax),is the most effective of a series of acyclic nucleosidesthat possess antiviral activity. In contrast with true nucleosidesthat have a ribose or a deoxyribose sugar attached to apurine or a pyrimidine base, the group attached to the basein acyclovir is similar to an open chain sugar, albeit lackingin hydroxyl groups. The clinically useful antiviral spectrumof acyclovir is limited to herpesviruses. It is most active (invitro) against HSV type 1, about two times less against HSVtype 2, and 10 times less potent against varicella–zostervirus (VZV).
The ultimate effect of acyclovir is the inhibition of viralDNA synthesis. Transport into the cell and monophosphorylationare accomplished by a thymidine kinase that is encodedby the virus itself.The affinity of acyclovir for the viralthymidine kinase is about 200 times that of the correspondingmammalian enzyme.
use: oral and parenteral. Oral acyclovir is used in the initialtreatment of genital herpes and to control mild recurrentepisodes. It has been approved for short-term treatment ofshingles and chickenpox caused by VZV. Intravenous administrationis indicated for initial and recurrent infectionsin immunocompromised patients and for the prevention andtreatment of severe episodes. The drug is absorbed slowlyand incompletely from the GI tract, and its oral bioavailabilityis only 15% to 30%. Nevertheless, acyclovir is distributedto virtually all body compartments.

Pharmaceutical Applications

A synthetic acyclic purine nucleoside analog of the natural nucleoside 2′ deoxyguanosine, formulated for oral and topical use, and as the sodium salt for intravenous infusion. Valaciclovir (the l-valyl ester) is a prodrug formulation supplied as the hydrochloride for oral use.

생물학적 활성

Antiviral agent, active against herpes simplex viruses HSV-1 and HSV-2 (EC 50 values are 0.85 and 0.86 μ M respectively). Interferes with viral DNA polymerization through competitive inhibition with guanosine triphosphate. Induces apoptosis in cells transfected with HSV-TK (suicidal gene therapy).

Clinical Use

Aciclovir
Herpes simplex keratitis
Chickenpox and herpes zoster
Herpes simplex encephalitis and neonatal herpes
Prophylaxis of HSV infections in the severely immunocompromised
Valaciclovir
Herpes zoster and genital HSV infections

에이사이클로비르 준비 용품 및 원자재

원자재

준비 용품


에이사이클로비르 공급 업체

글로벌( 906)공급 업체
공급자 전화 이메일 국가 제품 수 이점
APOLLO HEALTHCARE RESOURCES
+6596580999
sales@apollo-healthcare.com.sg Singapore 400 58
ZHEJIANG ESTCHEM CO.,LTD
15957180504
sales@zjestchem.com China 193 58
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12456 58
Hebei Lingding Biotechnology Co., Ltd.
+86-18031140164 +86-19933155420
erin@hbldbiotech.com China 878 58
Sinoway Industrial co., ltd.
0592-5800732; +8613806035118
xie@china-sinoway.com China 992 58
Hebei Dangtong Import and export Co LTD
+8615632927689
admin@hbdangtong.com China 991 58
Henan Tengmao Chemical Technology Co. LTD
+8615238638457
salesvip2@hntmhg.com China 415 58
Guangzhou Tengyue Chemical Co., Ltd.
+86-86-18148706580 +8618826483838
evan@tyvovo.com China 152 58
Shaanxi Haibo Biotechnology Co., Ltd
+undefined18602966907
qinhe02@xaltbio.com China 1000 58
Anhui Ruihan Technology Co., Ltd
+8617756083858
daisy@anhuiruihan.com China 994 58

에이사이클로비르 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved